Ідіопатична низкорослість: клініко-діагностичні критерії

О. В. Большова, О. Я. Самсон, Н. А. Спринчук, В. А. Музь, Т. О. Ткачова, О. В. Антропова

Повний текст:

PDF

Посилання


Noeker M. Management of idiopathic short stature: psychological endpoints, assessment strategies and cognitive-behavioral intervention / M. Noeker // Horm Res. – 2009. – N 1. – P. 75-81. https://doi.org/10.1159/000178044

ISS Consensus Workshop participants Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop / P. Cohen, A. D. Rogol, C.L. [et al.] // J. Clin. Endocrinol. Metab. – 2008. – Vol. 93. – N. 11. – P. 4210-4217. https://doi.org/10.1210/jc.2008-0509

Idiopathic short stature: definition, epidemiology, and diagnostic evaluation / J.M. Wit, P.E. Clayton, A.D. Rogol [et al.] // Growth Horm. IGF Res. – 2008. – Vol.18. – P. 89-110. https://doi.org/10.1016/j.ghir.2007.11.004

Idiopathic short stature: management and growth hormone treatment / J.M. Wit, E.O. Reiter, J.L. Ross [et al.] // Growth Horm IGF Res. – 2008. – Vol. 18. – P. 111-135. https://doi.org/10.1016/j.ghir.2007.11.003

Ranke M.B. Towards a consensus on the definition of idiopathic short stature / M.B. Ranke // Horm Res. – 1996. – Vol. 45 (Suppl. 2). – P. 64-66. https://doi.org/10.1159/000184851

Binder G. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone / G. Binder, C.P. Schwarze, M.B. Ranke // J. Clin. Endocrinol. Metab. – 2000. – N 85 (1). – P. 245-249. https://doi.org/10.1210/jcem.85.1.6375

Hujeirat Y. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature/ Y. Hujeirat, O. Hess, S. Shalev, Y. Tenenbaum-Rakover // Horm. Res. – 2006. – N 65 (4). – P. 210-216. https://doi.org/10.1159/000092514

Goddard A.D. Mutations of the growth hormone receptor in children with idiopathic short stature. / A.D. Goddard, R. Covello, S.M. Luoh [et al.], the Growth Hormone Insensitivity Study Group // N. Engl. J. Med. – 1995. – N 333 (17). – P. 1093-1098. https://doi.org/10.1056/nejm199510263331701

Attie K.M. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study / K.M. Attie, L.M. Carlsson, A.C. Rundle, B.M. Sherman // J. Pediatr. – 1995. – N 127 (2). – P. 244-250. https://doi.org/10.1016/s0022-3476(95)70302-0

Utah Growth Study: growth standards and the prevalence of growth hormone deficiency / R. Lindsay, M. Feldkamp, D. Harris [et al.] // J. Pediatr. – 1994. – Vol.125. – P.29-35. https://doi.org/10.1016/s0022-3476(94)70117-2

Hermanussen M. The calculation of target height reconsidered / M. Hermanussen, J. Cole // Horm. Res. – 2003. – Vol. 59. – P. 180-183. https://doi.org/10.1159/000069321

Luo Z.C. Target height as predicted by parental heights in a population-based study / Z.C. Luo, K. Albertsson-Wikland, J. Karlberg // Pediatr. Res. – 1998. – Vol. 44. – P. 563-571. https://doi.org/10.1203/00006450-199810000-00016

Centers for Disease Control CDC growth charts: United States. – 2000. – http://www.cdc.gov/growthcharts/

World Health Organization. The WHO child growth standards. – 2008. – http://www.who.int/childgrowth/en/

Cianfarani S. Naccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment / S. Cianfarani, A. Liguori, S. Boemi [et al.] // J. Clin. Endocrinol. Metab. – 2005. – Vol. 90. – P. 6028-6034. https://doi.org/10.1210/jc.2005-0721

Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo / J.L. Ross, D.E. Sandberg, S.R. Rose [et al.] // J. Clin. Endocrinol. Metab. – 2004. – Vol. 89. – P. 4873-4878. https://doi.org/10.1210/jc.2004-0791

Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children / J.E. Chaplin, B. Kristrom, B. Jonsson [et al.] / Horm. Res. Paediatr. – 2011. – Vol. 75 (4). – P. 291-303. https://doi.org/10.1159/000322937

Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group / L.T. Rekers-Mombarg, J.J. Busschbach, G.G. Massa [et al.] / Acta Paediatr. – 1998. – Vol. 87 (8). – P. 865- 870. https://doi.org/10.1111/j.1651-2227.1998.tb01553.x

Long-term psychosocial consequences of hormone treatment for short stature / H. Visser-van Balen, R. Geenen, G.A. Kamp [et al.] // Acta Paediatr. – 2007. – Vol. 96. – P. 715-719. https://doi.org/10.1111/j.1651-2227.2007.00235.x

Sandberg D.E. Growth hormone treatment of short stature: status of the quality of life rationale / D.E. Sandberg, M. Colsman // Horm. Res. – 2005. – Vol. 63. – P. 275-283. https://doi.org/10.1159/000086593

Allen D.B. Growth hormone for short stature: ethical issues raised by expanded access / D.B. Allen, N.C. Fost // J. Pediatr. – 2004. – Vol. 144. – P. 648-652. https://doi.org/10.1016/s0022-3476(04)00158-1


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.1(42).2013.77461



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter